Error: Could not add to watchlist. X

Fidelity Advisor Biotechnology Fund

+ Watchlist
FBTAX:US
NASDAQ GM
17.57
USD
0.16
0.92%
As of 9:29 AM EST on 2/10/2016.
Fund Type
Open-End Fund
52Wk Range
17.41 - 31.61
1 Yr Return
-28.30%
YTD Return
-32.73%
Previous Close
17.41
52Wk Range
17.41 - 31.61
1 Yr Return
-27.89%
YTD Return
-32.73%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 02/10/2016)
17.57
Total Assets (b USD) (on 01/29/2016)
2.696
Inception Date
12/27/2000
Last Dividend (on 09/11/2015)
0.32
Dividend Indicated Gross Yield
-
Fund Managers
RAJIV KAUL
Front Load Fee
5.75%
Back Load Fee
1.00%
Redemption Fee
0.75%
12b-1 Fee
0.25%
Current Mgmt Fee
0.55%
Expense Ratio
1.04%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 2.58 m 261.03 m 6.89
Celgene Corp 1.84 m 220.74 m 5.82
Alexion Pharmaceuticals Inc 1.14 m 218.06 m 5.75
Regeneron Pharmaceuticals Inc 386.12 k 209.61 m 5.53
Biogen Inc 653.14 k 200.09 m 5.28
Vertex Pharmaceuticals Inc 1.20 m 150.86 m 3.98
BioMarin Pharmaceutical Inc 1.42 m 148.53 m 3.92
Incyte Corp 1.12 m 121.71 m 3.21
Anacor Pharmaceuticals Inc 659.55 k 74.51 m 1.97
Medivation Inc 1.30 m 63.08 m 1.66
Profile
Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.
ADDRESS
Fidelity Investments
245 Summer Street
Boston, MA 02210
PHONE
1-800-544-6666